Public market insider selling at HEXO (HEXO)
Public market insider selling at HEXO (T:HEXO)
Updated Monday Sep 17, 2018 03:06 AM EDT
Pierre Maher Killeen, a Senior Officer, disposed of 108,550 Common Shares on a direct ownership basis at a price of $7.653 on September 11th, 2018. This represents a $830,733 divestment of the company's shares and an account share holdings change of -100.0%. Michael R. Munzar, a Director, disposed of 10,000 Common Shares on a direct ownership basis at a price of $8.832 on September 12th, 2018. This represents a $88,316 divestment of the company's shares and an account share holdings change of -6.7%.
HEXO is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Hexo Corp, formerly Hydropothecary Corp, is a Canada-based company that creates and distributes products to serve the Canadian cannabis market. The Company operates with an approximately 300,000 square feet of production capacity. The Company serves the adult-use market under the HEXO brand, while it serves its medical cannabis clients through the Hydropothecary brand. The following are the Company's products under the Hydropothecary brand: Time of Day product line, which includes dried marijuana buds for morning, midday, after dinner and bedtime; Hydrogen (H2) classical medical marijuana line, which includes Papaya Grove, Green Chai and Kush dried marijuana buds, among others; Decarb ready to consume activated marijuana powder; Elixir cannabis oil sublingual spray, as well as Fleur de Lune intimate cannabis oil.
Headlines: Sep 17, 2018
HEXO Insider Holdings Chart
Issuer details as of Sep 17, 2018 3:06 ET
Latest Price
7.70
1 Day Change
2.80%
52 Week High
8.95
52 Week Low
1.46
QMV ($Mils)
1,526,683,743